Skip to main content
Print Save

MYLAN 2260 MYLAN 2260 Pill - yellow purple capsule/oblong, 14mm

Pill with imprint MYLAN 2260 MYLAN 2260 is Yellow / Purple, Capsule/Oblong and has been identified as Terazosin Hydrochloride 1 mg. It is supplied by Mylan Pharmaceuticals Inc.

Terazosin is used in the treatment of Benign Prostatic Hyperplasia; High Blood Pressure and belongs to the drug classes alpha-adrenoreceptor antagonists, antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 1 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 2260 MYLAN 2260

Terazosin hydrochloride 1 mg MYLAN 2260 MYLAN 2260
Terazosin hydrochloride 1 mg MYLAN 2260 MYLAN 2260 Front
Terazosin hydrochloride 1 mg MYLAN 2260 MYLAN 2260 Back
Terazosin hydrochloride 1 mg MYLAN 2260 MYLAN 2260

Terazosin Hydrochloride

Imprint
MYLAN 2260 MYLAN 2260
Strength
1 mg
Color
Yellow / Purple
Size
14.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Alpha-adrenoreceptor antagonists, Antiadrenergic agents, peripherally acting
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
lactose anhydrous, silicon dioxide, D&C Red No. 28, D&C Red No. 33, FD&C Blue No. 1, magnesium stearate, microcrystalline cellulose, corn starch, sodium lauryl sulfate, titanium dioxide, ferric oxide yellow, ferrosoferric oxide, D&C Yellow No. 10, FD&C Blue No. 2, FD&C Red No. 40, propylene glycol, shellac

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00378-2260 (Discontinued) Mylan Pharmaceuticals Inc.
51079-0936 (Discontinued) UDL Laboratories Inc.
54569-4873 A-S Medication Solutions, LLC (repackager)
Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer